Clinical Trial Update: Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating safety and efficacy of umbilical cord mesenchymal stem cell transplantation in patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shanghai East Hospital | Conditions: Type 2 Diabetes, Mesenchymal Stem Cells | Phase 1, Phase 2 | Status: UNKNOWN